Viatris EPS VTRS

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026: n/m; a quarter missing
Latest quarter, Q2 FY26: −$0.10
Fiscal year 2023: $0.04; −98% on the year before

Viatris' twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.

In its latest quarter, Q2 FY26, it was −$0.10.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal year	EPS	Change
FY2023	$0.04	−98%
FY2022	$1.71	n/a
FY2021	−$1.05	n/a
FY2020	−$0.61	n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.10	n/a	n/a
Q1 FY26	Mar 31, 2026	$0.15	n/a	n/a
Q3 FY25	Sep 30, 2025	−$0.11	−238%	n/a
Q2 FY25	Jun 30, 2025	$0.00	n/a	n/a
Q1 FY25	Mar 31, 2025	−$2.55	−2933%	n/a
Q3 FY24	Sep 30, 2024	$0.08	−70%	−$0.74
Q2 FY24	Jun 30, 2024	−$0.27	−223%	−$0.55
Q1 FY24	Mar 31, 2024	$0.09	−53%	−$0.06
Q4 FY23	Dec 31, 2023	−$0.64	−177%	$0.04
Q3 FY23	Sep 30, 2023	$0.27	−7%	$1.51
Q2 FY23	Jun 30, 2023	$0.22	−15%	$1.53
Q1 FY23	Mar 31, 2023	$0.19	−42%	$1.57

Against its peers

Companies in Healthcare nearest Viatris' size, closest first, today.

Company	EPS, 12 months	Growth
VTRSViatris	n/m
THCTenet Healthcare	$25.93	+66% a year
STESTERIS	$8.18	+25% a year
ZBHZimmer Biomet	$4.11	+0% a year
MEDPMedpace	$17.05	+27% a year
INCYIncyte	$7.85	+78% a year
RVTYRevvity	$2.10	−11% a year
UTHRUnited Therapeutics	$27.95	+9% a year
LHLabcorp	$12.09	+33% a year
DGXQuest Diagnostics	$9.41	+18% a year
EXELExelixis	$3.18	+53% a year
Peer median	$8.79

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Viatris

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.